(RTTNews) - Below are the earnings highlights for Nektar Therapeutics (NKTR):
-Earnings: -$98.81 million in Q3 vs. -$96.14 million in the same period last year. -EPS: -$0.56 in Q3 vs. -$0.56 in the same period last year. -Analysts projected -$0.73 per share -Revenue: $29.22 million in Q3 vs. $27.76 million in the same period last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.